Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.1 trillion and total revenue of $110 billion.
Market Cap
1.1T
Revenue
110B
Profits
-41.87B
PE Ratio
n/a
Profit Margin
-38.06%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.39B | -0.76% | 357,562 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.83B | 1.09% | 298,760 | 14.92B |
| 3 | ARGX | argenx SE | 49.39B | 0.16% | 60,058 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.05B | -0.61% | 153,164 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.79B | 2.33% | 104,227 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.19B | 2.80% | 813,834 | - |
| 7 | RPRX | Royalty Pharma plc | 30.48B | 1.01% | 677,176 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.29B | 0.05% | 765,799 | 819.56M |
| 9 | ROIV | Roivant Sciences Ltd. | 22.92B | 13.51% | 6,624,853 | 13.31M |
| 10 | BNTX | BioNTech SE | 22.82B | 2.77% | 238,678 | 3.23B |
| 11 | INCY | Incyte Corporation | 19.43B | 1.74% | 228,636 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.94B | 4.40% | 1,460,803 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.79B | 4.44% | 4,082,607 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.02B | 0.83% | 139,336 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.77B | -0.07% | 89,503 | 998.25M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.23B | 7.57% | 1,179,335 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.20B | 2.15% | 594,957 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.47B | 1.95% | 590,606 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.32B | 0.92% | 359,021 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.83B | 1.44% | 190,885 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.70B | -0.86% | 51,967 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.59B | 2.75% | 325,462 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 10.49B | 1.07% | 544,868 | 105.82M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 9.57B | -0.56% | 592,980 | 3.24B |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.16B | 2.50% | 93,958 | 7.46M |
| 26 | ABVX | ABIVAX Société Anonyme | 8.97B | 4.41% | 560,994 | 5.37M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.76B | 1.36% | 52,878 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.58B | 5.54% | 14,779,687 | 140.98M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.10B | -0.64% | 294,652 | 1.51B |
| 30 | NUVL | Nuvalent, Inc. | 8.06B | 1.08% | 93,492 | - |
| 31 | TECH | Bio-Techne Corporation | 7.15B | 0.40% | 427,067 | 1.21B |
| 32 | IMVT | Immunovant, Inc. | 7.00B | 30.73% | 10,250,024 | - |
| 33 | PCVX | Vaxcyte, Inc. | 6.74B | -4.31% | 985,477 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.55B | 1.86% | 97,221 | 51.48M |
| 35 | CELC | Celcuity Inc. | 6.52B | 2.17% | 147,147 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.44B | 1.79% | 60,612 | 74.06M |
| 37 | CORT | Corcept Therapeutics Incorporated | 6.20B | -0.82% | 223,909 | 769.10M |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.06% | 238,282 | 15.00M |
| 39 | SYRE | Spyre Therapeutics, Inc. | 6.12B | 5.82% | 335,930 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.11B | 2.21% | 131,025 | 217.17M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.99B | 2.03% | 135,571 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.89B | 1.01% | 107,088 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 5.88B | 0.88% | 176,648 | 827.11M |
| 44 | BLTE | Belite Bio, Inc | 5.77B | 4.94% | 148,229 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.69B | -0.11% | 206,762 | - |
| 46 | CGON | CG Oncology, Inc. | 5.64B | 0.95% | 189,676 | 5.07M |
| 47 | TGTX | TG Therapeutics, Inc. | 5.63B | 0.74% | 347,502 | 700.35M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.54B | 3.71% | 426,281 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.35B | 2.33% | 159,214 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.12B | 2.23% | 363,579 | 1.14B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | 4.76% | 216,141 | 1.34M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.69B | 2.25% | 500,615 | 4.10M |
| 53 | CAI | Caris Life Sciences, Inc. | 4.35B | 2.87% | 492,845 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.35B | 4.43% | 33,845 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.33B | 5.14% | 123,738 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.01B | 3.41% | 391,146 | 22.57M |
| 57 | TVTX | Travere Therapeutics, Inc. | 3.98B | 1.28% | 299,720 | 536.20M |
| 58 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.08% | 474,571 | 596.96M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.79B | 2.92% | 135,950 | 18.07M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.56B | 2.59% | 529,151 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.55B | 1.17% | 371,160 | 1.10B |
| 62 | ERAS | Erasca, Inc. | 3.50B | 9.01% | 2,581,629 | - |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.48B | 2.93% | 209,324 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.37B | 2.25% | 448,995 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.36B | -0.09% | 42,699 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 2.99B | 1.75% | 610,317 | 56.99M |
| 67 | DNLI | Denali Therapeutics Inc. | 2.97B | 3.37% | 327,397 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 2.92B | 2.20% | 254,179 | 236.00M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.73B | 3.89% | 318,402 | - |
| 70 | ALMS | Alumis Inc. | 2.73B | -0.58% | 160,921 | 8.40M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | 2.66% | 61,063 | 535.08M |
| 72 | BEAM | Beam Therapeutics Inc. | 2.69B | 2.47% | 558,157 | 164.01M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.64B | 3.43% | 875,077 | - |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.63B | 3.47% | 48,971 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.58B | 3.57% | 150,976 | 225.27M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.56B | 4.97% | 411,977 | 415.62M |
| 77 | IRON | Disc Medicine, Inc. | 2.51B | 2.59% | 123,099 | - |
| 78 | ELVN | Enliven Therapeutics, Inc. | 2.47B | 0.92% | 155,917 | - |
| 79 | RLAY | Relay Therapeutics, Inc. | 2.45B | 5.80% | 2,183,283 | 10.68M |
| 80 | VERA | Vera Therapeutics, Inc. | 2.44B | 2.32% | 182,841 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.38B | 0.70% | 168,108 | 865.00K |
| 82 | NKTR | Nektar Therapeutics | 2.33B | 2.10% | 179,864 | 55.63M |
| 83 | IMNM | Immunome, Inc. | 2.26B | 1.68% | 177,355 | 4.02M |
| 84 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | 5.07% | 880,822 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.25B | 1.92% | 274,279 | 670.00M |
| 86 | DFTX | Definium Therapeutics, Inc. | 2.24B | 2.80% | 253,953 | - |
| 87 | KOD | Kodiak Sciences Inc. | 2.21B | 2.99% | 223,019 | - |
| 88 | NBTX | Nanobiotix S.A. | 2.16B | -6.82% | 54,275 | 38.27M |
| 89 | ZLAB | Zai Lab Limited | 2.07B | 0.44% | 157,071 | 453.28M |
| 90 | TYRA | Tyra Biosciences, Inc. | 2.04B | 1.30% | 231,113 | - |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 0.90% | 399,980 | 298.30M |
| 92 | ADMA | ADMA Biologics, Inc. | 2.01B | 0.35% | 772,958 | 509.86M |
| 93 | PHVS | Pharvaris N.V. | 1.94B | 2.37% | 59,204 | - |
| 94 | TRVI | Trevi Therapeutics, Inc. | 1.91B | 1.74% | 417,958 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 1.84B | -1.47% | 140,697 | 32.08M |
| 96 | MESO | Mesoblast Limited | 1.83B | -0.27% | 42,595 | 65.38M |
| 97 | AAPG | Ascentage Pharma Group International | 1.82B | 1.63% | 10,034 | 82.08M |
| 98 | VRDN | Viridian Therapeutics, Inc. | 1.82B | 3.32% | 417,872 | 70.92M |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 1.80B | 2.40% | 117,890 | 899.11M |
| 100 | ZYME | Zymeworks Inc. | 1.80B | 1.15% | 124,236 | 81.26M |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | 2.46% | 650,227 | 2.18B |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 4.13% | 197,498 | 217.17M |
| 103 | VCEL | Vericel Corporation | 1.78B | 1.07% | 99,324 | 292.09M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.78B | 1.50% | 1,340,292 | 52.04M |
| 105 | LKFT | Lakefront Biotherapeutics NV | 1.76B | 1.80% | 39,674 | 1.20B |
| 106 | ANAB | AnaptysBio, Inc. | 1.75B | 0.64% | 95,626 | 232.39M |
| 107 | GENB | Generate Biomedicines, Inc. | 1.70B | 7.49% | 280,800 | 30.30M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.70B | -0.19% | 130,414 | - |
| 109 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 2.60% | 91,428 | 66.05M |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 1.34% | 1,205,639 | 66.09M |
| 111 | RAPP | Rapport Therapeutics, Inc. | 1.68B | 1.92% | 56,414 | 20.00M |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.65B | 4.79% | 243,102 | 71.78M |
| 113 | INVA | Innoviva, Inc. | 1.65B | 2.90% | 148,448 | 420.69M |
| 114 | OCS | Oculis Holding AG | 1.64B | -0.61% | 117,465 | 1.40M |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.61B | 2.89% | 71,192 | - |
| 116 | IOVA | Iovance Biotherapeutics, Inc. | 1.61B | 4.05% | 3,094,733 | 285.61M |
| 117 | SLS | SELLAS Life Sciences Group, Inc. | 1.59B | 12.91% | 8,555,547 | - |
| 118 | CAPR | Capricor Therapeutics, Inc. | 1.58B | 1.19% | 267,568 | 11.13M |
| 119 | INBX | Inhibrx Biosciences, Inc. | 1.56B | -3.21% | 74,666 | 1.30M |
| 120 | QURE | uniQure N.V. | 1.54B | -0.93% | 144,741 | 18.09M |
| 121 | ARDX | Ardelyx, Inc. | 1.54B | 2.46% | 715,913 | 427.68M |
| 122 | GLUE | Monte Rosa Therapeutics, Inc. | 1.54B | 3.70% | 223,593 | 42.95M |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.53B | 2.80% | 657,834 | 7.47M |
| 124 | RXRX | Recursion Pharmaceuticals, Inc. | 1.53B | 1.05% | 3,418,107 | 66.41M |
| 125 | NVAX | Novavax, Inc. | 1.52B | 3.54% | 1,803,501 | 596.34M |
| 126 | PGEN | Precigen, Inc. | 1.52B | 2.16% | 1,028,903 | 31.60M |
| 127 | GHRS | GH Research PLC | 1.51B | 0.27% | 86,902 | - |
| 128 | NUVB | Nuvation Bio Inc. | 1.49B | 1.18% | 1,098,698 | 143.05M |
| 129 | IMTX | Immatics N.V. | 1.49B | 3.93% | 107,498 | 43.00M |
| 130 | IMCR | Immunocore Holdings plc | 1.49B | 0.95% | 223,272 | 412.81M |
| 131 | ATAI | AtaiBeckley Inc. | 1.48B | 1.64% | 1,253,217 | 3.49M |
| 132 | MBX | MBX Biosciences, Inc. | 1.47B | 1.88% | 244,564 | - |
| 133 | DMRA | Damora Therapeutics, Inc. | 1.47B | 1.58% | 48,501 | - |
| 134 | VIR | Vir Biotechnology, Inc. | 1.46B | 1.76% | 683,258 | 65.50M |
| 135 | URGN | UroGen Pharma Ltd. | 1.43B | 3.79% | 141,260 | 140.49M |
| 136 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.09% | 1,793,670 | 114.48M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.39B | 2.37% | 67,421 | 20.00M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.35B | 2.35% | 64,596 | - |
| 139 | ABCL | AbCellera Biologics Inc. | 1.34B | 8.64% | 2,685,651 | 79.21M |
| 140 | BHVN | Biohaven Ltd. | 1.34B | 5.84% | 648,772 | - |
| 141 | FTRE | Fortrea Holdings Inc. | 1.26B | -2.92% | 200,235 | 2.71B |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.25B | 1.55% | 30,976 | - |
| 143 | SVRA | Savara Inc. | 1.24B | 3.60% | 285,727 | - |
| 144 | SEPN | Septerna, Inc. | 1.24B | 3.77% | 54,336 | 72.26M |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.23B | 3.12% | 169,389 | - |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.23B | 0.73% | 70,670 | - |
| 147 | WVE | Wave Life Sciences Ltd. | 1.19B | 0.98% | 1,481,222 | 71.80M |
| 148 | OLMA | Olema Pharmaceuticals, Inc. | 1.18B | 2.75% | 151,245 | - |
| 149 | COAG | Hemab Therapeutics Holdings, Inc. | 1.15B | 2.22% | 67,415 | - |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.15B | 1.91% | 61,426 | 10.00M |
| 151 | AVLN | Avalyn Pharma Inc. | 1.13B | -3.95% | 73,676 | - |
| 152 | DBVT | DBV Technologies S.A. | 1.10B | 0.35% | 32,529 | 5.74M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.09B | 1.28% | 83,044 | - |
| 154 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.08B | -0.95% | 1,542,907 | 204.73M |
| 155 | AKTS | Aktis Oncology, Inc. | 1.04B | 2.16% | 25,525 | 8.28M |
| 156 | EYPT | EyePoint, Inc. | 1.04B | 5.16% | 215,812 | 7.61M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | 6.00% | 628,797 | - |
| 158 | IVA | Inventiva S.A. | 1.02B | 3.87% | 27,952 | 7.94M |
| 159 | LXRX | Lexicon Pharmaceuticals, Inc. | 990.35M | 4.69% | 572,107 | 69.64M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 964.59M | 2.62% | 373,523 | - |
| 161 | MNKD | MannKind Corporation | 960.84M | 5.07% | 950,068 | 360.78M |
| 162 | PHAT | Phathom Pharmaceuticals, Inc. | 920.59M | 1.67% | 159,008 | 204.89M |
| 163 | CGEM | Cullinan Therapeutics, Inc. | 898.52M | 3.14% | 297,456 | - |
| 164 | PHAR | Pharming Group N.V. | 895.41M | 1.35% | 2,566 | 369.49M |
| 165 | MGTX | MeiraGTx Holdings plc | 883.03M | 4.44% | 280,189 | 79.76M |
| 166 | OMER | Omeros Corporation | 880.81M | 1.67% | 225,961 | 9.89M |
| 167 | ABUS | Arbutus Biopharma Corporation | 865.22M | 4.29% | 532,926 | 191.45M |
| 168 | JANX | Janux Therapeutics, Inc. | 858.05M | 1.88% | 451,038 | 13.73M |
| 169 | SANA | Sana Biotechnology, Inc. | 857.14M | 0.65% | 764,993 | - |
| 170 | KURA | Kura Oncology, Inc. | 848.68M | 6.70% | 1,639,043 | 71.64M |
| 171 | SPTX | Seaport Therapeutics, Inc. | 846.85M | 1.98% | 107,747 | - |
| 172 | TBPH | Theravance Biopharma, Inc. | 842.38M | 0.55% | 102,545 | 109.78M |
| 173 | ORIC | ORIC Pharmaceuticals, Inc. | 841.60M | 2.01% | 206,518 | - |
| 174 | AURA | Aura Biosciences, Inc. | 832.76M | 2.17% | 117,843 | - |
| 175 | ANNX | Annexon, Inc. | 812.66M | 1.02% | 556,702 | - |
| 176 | VOR | Vor Biopharma Inc. | 811.16M | 5.94% | 266,887 | - |
| 177 | ODTX | Odyssey Therapeutics, Inc. | 810.45M | 1.42% | 82,088 | 2.98M |
| 178 | GERN | Geron Corporation | 805.11M | 2.87% | 2,228,262 | 196.12M |
| 179 | XNCR | Xencor, Inc. | 804.07M | 4.18% | 174,859 | 97.36M |
| 180 | AVTX | Avalo Therapeutics, Inc. | 803.05M | 0.61% | 368,185 | 59.00K |
| 181 | CTMX | CytomX Therapeutics, Inc. | 797.88M | 0.69% | 528,128 | 35.54M |
| 182 | LBRX | LB Pharmaceuticals Inc | 797.21M | 1.94% | 42,604 | - |
| 183 | EVMN | Evommune, Inc. | 792.40M | 4.17% | 59,773 | 10.00M |
| 184 | ABSI | Absci Corporation | 753.02M | 4.32% | 1,093,584 | 1.84M |
| 185 | SPRY | ARS Pharmaceuticals, Inc. | 743.78M | 4.46% | 346,465 | 98.99M |
| 186 | DRUG | Bright Minds Biosciences Inc. | 739.49M | 8.65% | 58,107 | - |
| 187 | ANRO | Alto Neuroscience, Inc. | 728.75M | 1.66% | 55,222 | - |
| 188 | SGP | SpyGlass Pharma, Inc. | 727.03M | 2.59% | 5,339 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 723.73M | -1.85% | 180,253 | - |
| 190 | TENX | Tenax Therapeutics, Inc. | 712.43M | 5.45% | 156,752 | - |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 712.29M | 2.06% | 51,642 | - |
| 192 | DSGN | Design Therapeutics, Inc. | 678.91M | 3.62% | 881,939 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 652.34M | - | 1,543,040 | 22.00K |
| 194 | CBIO | Crescent Biopharma, Inc. | 647.63M | 5.47% | 11,075 | 11.88M |
| 195 | SLDB | Solid Biosciences Inc. | 627.12M | 4.77% | 344,697 | - |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 622.90M | 0.22% | 185,494 | 8.37M |
| 197 | ZVRA | Zevra Therapeutics, Inc. | 611.25M | 1.37% | 315,182 | 122.29M |
| 198 | CRMD | CorMedix Inc. | 606.04M | -1.21% | 351,911 | 400.05M |
| 199 | EIKN | Eikon Therapeutics, Inc. | 605.81M | 5.17% | 42,119 | - |
| 200 | TRAX | First Tracks Biotherapeutics, Inc. | 587.59M | 1.08% | 96,080 | - |
| 201 | CADL | Candel Therapeutics, Inc. | 576.64M | 2.74% | 420,198 | - |
| 202 | ARVN | Arvinas, Inc. | 572.95M | 3.86% | 217,512 | 89.40M |
| 203 | GYRE | Gyre Therapeutics, Inc. | 552.80M | -3.35% | 58,985 | 117.05M |
| 204 | MDXG | MiMedx Group, Inc. | 551.10M | 1.65% | 217,570 | 389.42M |
| 205 | CABA | Cabaletta Bio, Inc. | 547.85M | 2.75% | 1,080,904 | - |
| 206 | ALT | Altimmune, Inc. | 545.50M | 2.37% | 736,571 | 36.00K |
| 207 | VALN | Valneva SE | 537.83M | 2.26% | 19,792 | 180.25M |
| 208 | TECX | Tectonic Therapeutic, Inc. | 531.17M | 3.15% | 26,420 | - |
| 209 | KYTX | Kyverna Therapeutics, Inc. | 528.43M | 0.34% | 190,982 | - |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 527.86M | 0.81% | 41,921 | 299.77M |
| 211 | XOMA | XOMA Royalty Corporation | 523.27M | 0.45% | 21,601 | 48.56M |
| 212 | AGMB | AgomAb Therapeutics NV | 519.07M | 0.29% | 5,098 | - |
| 213 | STRO | Sutro Biopharma, Inc. | 513.27M | -2.18% | 125,164 | 99.61M |
| 214 | FBRX | Forte Biosciences, Inc. | 499.10M | 1.77% | 54,685 | - |
| 215 | PRME | Prime Medicine, Inc. | 498.50M | 2.22% | 743,079 | 4.03M |
| 216 | CTNM | Contineum Therapeutics, Inc. | 497.24M | 4.23% | 55,057 | - |
| 217 | CLYM | Climb Bio, Inc. | 494.40M | 7.25% | 115,029 | - |
| 218 | PROK | ProKidney Corp. | 493.71M | 5.48% | 162,580 | 889.00K |
| 219 | DNA | Ginkgo Bioworks Holdings, Inc. | 492.87M | 2.51% | 125,152 | 151.40M |
| 220 | PRTA | Prothena Corporation plc | 487.41M | 2.65% | 115,242 | 57.94M |
| 221 | ACHV | Achieve Life Sciences, Inc. | 468.13M | 2.47% | 227,480 | - |
| 222 | IMMX | Immix Biopharma, Inc. | 463.33M | -1.35% | 249,200 | - |
| 223 | VTVT | vTv Therapeutics Inc. | 455.43M | 0.58% | 16,133 | 36.84M |
| 224 | STTK | Shattuck Labs, Inc. | 454.25M | 3.80% | 69,238 | 1.00M |
| 225 | OCGN | Ocugen, Inc. | 450.23M | 2.31% | 1,055,715 | 4.47M |
| 226 | UPB | Upstream Bio, Inc. | 448.42M | 2.62% | 147,702 | 3.32M |
| 227 | FDMT | 4D Molecular Therapeutics, Inc. | 446.96M | 1.73% | 108,322 | 88.24M |
| 228 | PRLD | Prelude Therapeutics Incorporated | 442.54M | 3.04% | 179,753 | 16.72M |
| 229 | AUTL | Autolus Therapeutics plc | 441.80M | 1.84% | 518,097 | 92.62M |
| 230 | ANL | Adlai Nortye Ltd. | 435.20M | 1.68% | 59,675 | 5.00M |
| 231 | ASMB | Assembly Biosciences, Inc. | 427.67M | 1.47% | 42,622 | 71.10M |
| 232 | NGNE | Neurogene Inc. | 426.65M | 0.45% | 24,114 | 925.00K |
| 233 | PRTC | PureTech Health plc | 423.21M | 4.45% | 1,387 | 4.66M |
| 234 | OVID | Ovid Therapeutics Inc. | 417.02M | 0.42% | 211,964 | 7.12M |
| 235 | FULC | Fulcrum Therapeutics, Inc. | 414.46M | 5.25% | 113,346 | 80.00M |
| 236 | ADCT | ADC Therapeutics SA | 407.65M | 2.07% | 186,719 | 79.18M |
| 237 | ENTA | Enanta Pharmaceuticals, Inc. | 407.39M | 1.82% | 30,248 | 69.21M |
| 238 | SGMT | Sagimet Biosciences Inc. | 406.33M | 0.61% | 105,641 | - |
| 239 | REPL | Replimune Group, Inc. | 406.26M | 4.68% | 1,355,907 | - |
| 240 | LYEL | Lyell Immunopharma, Inc. | 396.19M | 5.27% | 14,948 | 31.00K |
| 241 | IPSC | Century Therapeutics, Inc. | 394.07M | 3.07% | 164,666 | 109.16M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 391.44M | 3.50% | 27,103 | - |
| 243 | ZURA | Zura Bio Limited | 389.01M | 2.76% | 210,465 | - |
| 244 | MNPR | Monopar Therapeutics Inc. | 388.60M | 5.09% | 59,017 | - |
| 245 | ARTV | Artiva Biotherapeutics, Inc. | 378.99M | -8.77% | 345,254 | 251.00K |
| 246 | BNTC | Benitec Biopharma Inc. | 376.18M | 2.15% | 16,743 | - |
| 247 | VSTM | Verastem, Inc. | 371.71M | 1.93% | 508,171 | 49.59M |
| 248 | OABI | OmniAb, Inc. | 369.68M | 7.59% | 511,821 | 28.94M |
| 249 | VNDA | Vanda Pharmaceuticals Inc. | 368.33M | 2.25% | 190,149 | 217.78M |
| 250 | GLSI | Greenwich LifeSciences, Inc. | 367.98M | 0.95% | 50,266 | - |
| 251 | LXEO | Lexeo Therapeutics, Inc. | 362.77M | 3.12% | 187,606 | - |
| 252 | CCCC | C4 Therapeutics, Inc. | 360.29M | 5.14% | 465,818 | 34.86M |
| 253 | IFRX | InflaRx N.V. | 360.13M | 3.16% | 158,522 | 33.82K |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 358.41M | 4.40% | 52,745 | 9.01M |
| 255 | LRMR | Larimar Therapeutics, Inc. | 356.99M | 2.70% | 493,177 | - |
| 256 | PBYI | Puma Biotechnology, Inc. | 352.22M | 1.62% | 74,344 | 227.18M |
| 257 | FENC | Fennec Pharmaceuticals Inc. | 343.20M | 1.23% | 30,747 | 51.00M |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 336.11M | 1.20% | 51,567 | - |
| 259 | RZLT | Rezolute, Inc. | 335.34M | 3.55% | 429,154 | - |
| 260 | CMPX | Compass Therapeutics, Inc. | 327.76M | 0.55% | 848,586 | 850.00K |
| 261 | RCKT | Rocket Pharmaceuticals, Inc. | 325.94M | 2.23% | 692,992 | - |
| 262 | IMRX | Immuneering Corporation | 325.10M | 2.76% | 146,216 | - |
| 263 | NMRA | Neumora Therapeutics, Inc. | 317.88M | 4.19% | 278,803 | - |
| 264 | PALI | Palisade Bio, Inc. | 313.92M | 3.59% | 895,452 | - |
| 265 | IRD | Opus Genetics, Inc. | 312.03M | 2.58% | 99,121 | 11.98M |
| 266 | LCTX | Lineage Cell Therapeutics, Inc. | 311.62M | 4.17% | 297,162 | 14.78M |
| 267 | YDES | YD Bio Limited | 307.28M | -12.51% | 8,988 | 510.36K |
| 268 | BCYC | Bicycle Therapeutics plc | 305.32M | 0.69% | 172,282 | 63.50M |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 303.90M | 1.26% | 53,781 | - |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 303.08M | 0.21% | 81,137 | - |
| 271 | SRZN | Surrozen, Inc. | 301.99M | 2.82% | 30,914 | 7.49M |
| 272 | SLN | Silence Therapeutics plc | 299.00M | 9.71% | 28,084 | 839.00K |
| 273 | NGEN | NervGen Pharma Corp. | 298.63M | 3.65% | 27,454 | - |
| 274 | IVVD | Invivyd, Inc. | 298.36M | 1.44% | 578,617 | 55.87M |
| 275 | ABEO | Abeona Therapeutics Inc. | 297.51M | 1.95% | 255,382 | 14.54M |
| 276 | NAGE | Niagen Bioscience, Inc. | 294.10M | 0.41% | 201,628 | 130.42M |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 288.97M | -6.91% | 10,951 | 5.20M |
| 278 | RGNX | REGENXBIO Inc. | 288.47M | -1.41% | 481,637 | 87.82M |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 287.56M | 3.91% | 323,948 | - |
| 280 | ACIU | AC Immune SA | 285.70M | 2.13% | 63,103 | 4.62M |
| 281 | MGNX | MacroGenics, Inc. | 285.38M | -0.66% | 260,108 | 157.08M |
| 282 | NVCT | Nuvectis Pharma, Inc. | 285.28M | 4.42% | 45,964 | - |
| 283 | IKT | Inhibikase Therapeutics, Inc. | 276.08M | 3.18% | 143,553 | 1.00 |
| 284 | CLLS | Cellectis S.A. | 272.52M | 2.48% | 1,906 | 75.11M |
| 285 | ALXO | ALX Oncology Holdings Inc. | 266.43M | 1.02% | 214,457 | - |
| 286 | SABS | SAB Biotherapeutics, Inc. | 266.27M | 6.73% | 233,497 | 114.70K |
| 287 | CGEN | Compugen Ltd. | 260.97M | 1.10% | 85,533 | 72.66M |
| 288 | TARA | Protara Therapeutics, Inc. | 251.79M | 3.23% | 171,875 | - |
| 289 | AVXL | Anavex Life Sciences Corp. | 250.21M | 1.12% | 208,267 | - |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 249.86M | -0.85% | 381,927 | 26.87M |
| 291 | EDIT | Editas Medicine, Inc. | 246.72M | 2.44% | 231,707 | 38.69M |
| 292 | ALEC | Alector, Inc. | 245.37M | 4.74% | 262,166 | 18.42M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 239.22M | -0.12% | 17,031 | 32.72M |
| 294 | CHRS | Coherus Oncology, Inc. | 237.54M | 4.05% | 286,040 | 46.88M |
| 295 | TNXP | Tonix Pharmaceuticals Holding Corp. | 232.58M | 6.42% | 74,576 | 17.56M |
| 296 | CAMP | Camp4 Therapeutics Corporation | 228.99M | 6.27% | 4,388 | 3.93M |
| 297 | ADAG | Adagene Inc. | 226.63M | 0.88% | 15,479 | 7.67M |
| 298 | CDXS | Codexis, Inc. | 226.33M | 1.22% | 212,468 | 78.09M |
| 299 | FATE | Fate Therapeutics, Inc. | 222.63M | 1.06% | 771,490 | 6.32M |
| 300 | RNA | Atrium Therapeutics, Inc. | 219.47M | -0.93% | 21,146 | 36.68M |
| 301 | LENZ | LENZ Therapeutics, Inc. | 219.17M | 5.11% | 240,249 | 20.99M |
| 302 | FHTX | Foghorn Therapeutics Inc. | 219.00M | 3.61% | 45,631 | 28.22M |
| 303 | SLGL | Sol-Gel Technologies Ltd. | 217.37M | 5.03% | 6,070 | 19.39M |
| 304 | MDWD | MediWound Ltd. | 216.82M | 1.11% | 6,358 | 16.96M |
| 305 | HELP | Cybin Inc. | 215.15M | 2.87% | 184,502 | - |
| 306 | TRDA | Entrada Therapeutics, Inc. | 214.40M | 5.31% | 66,879 | 5.74M |
| 307 | NERV | Minerva Neurosciences, Inc. | 213.38M | 5.05% | 165,199 | - |
| 308 | VYGR | Voyager Therapeutics, Inc. | 212.08M | 0.86% | 158,039 | 36.49M |
| 309 | KROS | Keros Therapeutics, Inc. | 206.43M | 5.25% | 96,670 | 33.18M |
| 310 | UNCY | Unicycive Therapeutics, Inc. | 203.99M | -1.16% | 194,529 | - |
| 311 | BDTX | Black Diamond Therapeutics, Inc. | 202.28M | 17.67% | 3,382,572 | 70.00M |
| 312 | WHWK | Whitehawk Therapeutics, Inc. | 202.16M | 0.49% | 34,992 | 7.15M |
| 313 | NBP | NovaBridge Biosciences | 200.07M | 2.98% | 387,862 | - |
| 314 | MIST | Milestone Pharmaceuticals Inc. | 199.99M | 2.80% | 352,726 | 1.78M |
| 315 | CNTX | Context Therapeutics Inc. | 199.38M | - | 91,058 | - |
| 316 | NKTX | Nkarta, Inc. | 198.90M | 3.73% | 128,479 | - |
| 317 | CRBU | Caribou Biosciences, Inc. | 198.48M | 2.54% | 554,879 | 11.20M |
| 318 | IPHA | Innate Pharma S.A. | 196.91M | 10.84% | 13,992 | 10.57M |
| 319 | RNAC | Cartesian Therapeutics, Inc. | 195.97M | 9.52% | 49,410 | 1.78M |
| 320 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.71M | 1.35% | 143,638 | 54.71M |
| 321 | HUMA | Humacyte, Inc. | 190.11M | 3.76% | 1,526,765 | 2.02M |
| 322 | DTIL | Precision BioSciences, Inc. | 187.32M | 5.22% | 35,878 | 45.07M |
| 323 | ELTX | Elicio Therapeutics, Inc. | 186.17M | 10.36% | 29,270 | - |
| 324 | CNTN | Canton Strategic Holdings, Inc. | 184.42M | -0.31% | 79,200 | - |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 177.80M | 4.04% | 753,973 | 225.00K |
| 326 | KPTI | Karyopharm Therapeutics Inc. | 177.70M | 5.49% | 242,244 | 151.12M |
| 327 | TLSA | Tiziana Life Sciences Ltd | 177.40M | 0.72% | 30,557 | - |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 171.90M | -1.85% | 55,681 | 2.00M |
| 329 | ENLV | Enlivex Ltd. | 171.14M | 0.78% | 39,732 | - |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 168.32M | 3.72% | 127,890 | - |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 166.85M | 6.45% | 183,276 | - |
| 332 | ANTX | AN2 Therapeutics, Inc. | 163.42M | -0.22% | 13,492 | - |
| 333 | MENS | Jyong Biotech Ltd. | 161.50M | -3.67% | 13,904 | - |
| 334 | PRQR | ProQR Therapeutics N.V. | 161.20M | 6.99% | 112,529 | 15.73M |
| 335 | HRTX | Heron Therapeutics, Inc. | 160.89M | 0.22% | 832,020 | 150.71M |
| 336 | PLYX | Polaryx Therapeutics, Inc. | 159.55M | 10.13% | 57,641 | - |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 157.11M | 2.63% | 114,148 | 76.38M |
| 338 | SPRO | Spero Therapeutics, Inc. | 151.41M | 0.97% | 164,571 | 61.19M |
| 339 | HURA | TuHURA Biosciences, Inc. | 150.93M | -3.66% | 317,404 | - |
| 340 | IMUX | Immunic, Inc. | 150.38M | -4.83% | 45,530 | - |
| 341 | OKUR | OnKure Therapeutics, Inc. | 146.84M | 10.15% | 65,756 | - |
| 342 | KZIA | Kazia Therapeutics Limited | 145.69M | 5.55% | 29,512 | 1.27M |
| 343 | GALT | Galectin Therapeutics Inc. | 142.85M | 4.33% | 83,064 | - |
| 344 | TTRX | Turn Therapeutics Inc. | 138.22M | 1.98% | 15,796 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 136.57M | 4.75% | 16,655 | 697.00K |
| 346 | KRRO | Korro Bio, Inc. | 135.43M | 2.62% | 25,632 | 3.84M |
| 347 | MOLN | Molecular Partners AG | 135.42M | 3.21% | 7,972 | 856.30K |
| 348 | NTHI | NeOnc Technologies Holdings, Inc. | 134.64M | -2.46% | 32,656 | 39.99K |
| 349 | AGEN | Agenus Inc. | 132.92M | 3.56% | 114,530 | 123.87M |
| 350 | GUTS | Fractyl Health, Inc. | 132.90M | 2.52% | 497,966 | 3.00K |
| 351 | ALPS | Alps Group Inc | 132.22M | 2.70% | 7,139 | 3.74M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 131.13M | 5.94% | 125,333 | 233.00K |
| 353 | ACOG | Alpha Cognition Inc. | 130.86M | 3.62% | 10,729 | 10.83M |
| 354 | PYXS | Pyxis Oncology, Inc. | 128.23M | 6.81% | 192,728 | 13.86M |
| 355 | GNLX | Genelux Corporation | 127.45M | 2.50% | 21,553 | 8.00K |
| 356 | CRDF | Cardiff Oncology, Inc. | 127.17M | 5.68% | 728,723 | 525.00K |
| 357 | EQ | Equillium, Inc. | 119.50M | 7.08% | 69,130 | 4.39M |
| 358 | COYA | Coya Therapeutics, Inc. | 109.17M | 1.84% | 13,520 | 7.94M |
| 359 | CGTX | Cognition Therapeutics, Inc. | 108.56M | 9.46% | 674,397 | - |
| 360 | KLRS | Kalaris Therapeutics, Inc. | 108.52M | 0.43% | 10,053 | - |
| 361 | RANI | Rani Therapeutics Holdings, Inc. | 107.79M | 22.11% | 928,291 | 3.17M |
| 362 | ENGN | enGene Therapeutics Inc. | 107.18M | 4.58% | 658,667 | - |
| 363 | CBUS | Cibus, Inc. | 105.27M | 6.15% | 95,848 | 4.29M |
| 364 | INO | Inovio Pharmaceuticals, Inc. | 103.24M | 3.28% | 957,436 | 65.34K |
| 365 | VRCA | Verrica Pharmaceuticals Inc. | 102.56M | 6.80% | 4,188 | 37.16M |
| 366 | VANI | Vivani Medical, Inc. | 100.90M | 1.74% | 46,063 | - |
| 367 | QTTB | Q32 Bio Inc. | 99.20M | -3.62% | 45,794 | 53.74M |
| 368 | NRXP | NRx Pharmaceuticals, Inc. | 97.29M | -2.81% | 510,484 | 2.29M |
| 369 | SEER | Seer, Inc. | 96.48M | 1.79% | 55,935 | 15.17M |
| 370 | PEPG | PepGen Inc. | 96.15M | 0.72% | 245,283 | - |
| 371 | EDSA | Edesa Biotech, Inc. | 95.52M | -10.04% | 248,532 | - |
| 372 | PMN | ProMIS Neurosciences, Inc. | 94.66M | -0.89% | 1,328 | - |
| 373 | ONCY | Oncolytics Biotech Inc. | 93.60M | 4.00% | 142,823 | - |
| 374 | AARD | Aardvark Therapeutics, Inc. | 93.37M | -2.06% | 26,664 | - |
| 375 | PYPD | PolyPid Ltd. | 93.13M | 2.52% | 72,350 | - |
| 376 | ICCC | ImmuCell Corporation | 92.73M | 0.49% | 3,967 | 29.93M |
| 377 | ANIX | Anixa Biosciences, Inc. | 92.54M | 3.37% | 63,106 | - |
| 378 | ALDX | Aldeyra Therapeutics, Inc. | 91.69M | -1.30% | 267,661 | - |
| 379 | BMEA | Biomea Fusion, Inc. | 91.10M | 3.28% | 407,823 | - |
| 380 | PTHS | Pelthos Therapeutics Inc. | 90.77M | 0.19% | 3,432 | 27.70M |
| 381 | LONA | LeonaBio, Inc. | 90.08M | -4.96% | 9,327 | - |
| 382 | FBIO | Fortress Biotech, Inc. | 88.53M | 5.34% | 161,064 | 66.16M |
| 383 | NRXS | NeurAxis, Inc. | 85.43M | 2.41% | 19,082 | 4.28M |
| 384 | CSBR | Champions Oncology, Inc. | 84.71M | 2.01% | 1,569 | 57.95M |
| 385 | OKYO | OKYO Pharma Limited | 84.49M | 0.63% | 7,691 | - |
| 386 | ACET | Adicet Bio, Inc. | 78.76M | 3.45% | 53,821 | - |
| 387 | EXOZ | eXoZymes, Inc. | 78.18M | -2.95% | 2,431 | -700.00 |
| 388 | MAIA | MAIA Biotechnology, Inc. | 78.13M | 4.47% | 143,330 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 77.63M | -3.08% | 13,650 | 23.14M |
| 390 | RNTX | Rein Therapeutics Inc. | 76.63M | -1.31% | 221,739 | - |
| 391 | OSTX | OS Therapies Incorporated | 76.51M | 3.41% | 227,637 | - |
| 392 | HYFT | MindWalk Holdings Corp. | 75.49M | 20.63% | 1,557,909 | 20.70M |
| 393 | RLYB | Rallybio Corporation | 75.27M | 0.28% | 6,262 | 858.00K |
| 394 | MCRB | Seres Therapeutics, Inc. | 74.37M | 3.23% | 2,745 | 1.15M |
| 395 | ATHE | Alterity Therapeutics Limited | 73.22M | 4.10% | 226 | 4.43M |
| 396 | XBIT | XBiotech Inc. | 72.87M | 0.84% | 11,914 | - |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 71.91M | 5.00% | 59,408 | - |
| 398 | PLRX | Pliant Therapeutics, Inc. | 71.83M | 0.87% | 57,068 | - |
| 399 | GANX | Gain Therapeutics, Inc. | 71.02M | 4.72% | 170,868 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 69.33M | -0.76% | 34,550 | - |
| 401 | MNOV | MediciNova, Inc. | 67.93M | - | 6,183 | 596.64K |
| 402 | CUE | Cue Biopharma, Inc. | 67.29M | 1.82% | 61,317 | 32.73M |
| 403 | ANVS | Annovis Bio, Inc. | 66.87M | -0.52% | 2,125,168 | - |
| 404 | IMA | ImageneBio, Inc. | 61.92M | 4.57% | 3,845 | 800.00K |
| 405 | IMMP | Immutep Limited | 61.62M | -7.11% | 532,207 | 5.28M |
| 406 | LIXT | Lixte Biotechnology Holdings, Inc. | 61.58M | 0.57% | 5,623 | - |
| 407 | ENTX | Entera Bio Ltd. | 61.53M | -1.57% | 5,631 | 42.00K |
| 408 | TCRX | TScan Therapeutics, Inc. | 60.70M | 4.87% | 124,397 | 9.14M |
| 409 | IBIO | iBio, Inc. | 60.36M | 11.33% | 238,725 | 300.00K |
| 410 | DWTX | Dogwood Therapeutics, Inc. | 60.18M | -2.61% | 4,142 | - |
| 411 | PDSB | PDS Biotechnology Corporation | 60.00M | 7.50% | 275,373 | - |
| 412 | FLNA | Filana Therapeutics, Inc. | 59.90M | 3.33% | 50,217 | - |
| 413 | ACTU | Actuate Therapeutics, Inc. | 58.86M | 2.50% | 22,233 | - |
| 414 | IBO | Impact BioMedical Inc. | 56.82M | -2.10% | 1,967 | 39.00K |
| 415 | CING | Cingulate Inc. | 55.25M | 2.73% | 76,397 | - |
| 416 | TIL | Instil Bio, Inc. | 55.07M | 1.25% | 19,480 | - |
| 417 | BYSI | BeyondSpring Inc. | 53.87M | 1.55% | 3,972 | 1.88M |
| 418 | INKT | MiNK Therapeutics, Inc. | 53.16M | 3.09% | 14,397 | - |
| 419 | RADX | Radiopharm Theranostics Limited | 52.75M | -3.02% | 6,801 | 10.86M |
| 420 | ATYR | aTyr Pharma, Inc. | 52.16M | 10.14% | 1,148,633 | 190.00K |
| 421 | HYPD | Hyperion DeFi, Inc. | 51.57M | 5.68% | 202,936 | 1.04M |
| 422 | ESLA | Estrella Immunopharma, Inc. | 49.92M | 2.63% | 897 | - |
| 423 | KALA | KALA BIO, Inc. | 49.45M | 5.14% | 31,078 | - |
| 424 | XLO | Xilio Therapeutics, Inc. | 48.79M | -0.31% | 1,549 | 53.48M |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 48.00M | 2.00% | 76,434 | 22.33M |
| 426 | GOSS | Gossamer Bio, Inc. | 47.03M | 0.65% | 4,233,193 | 55.54M |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 44.35M | 5.74% | 55,875 | - |
| 428 | PSTV | Plus Therapeutics, Inc. | 42.89M | 7.20% | 54,451 | 5.18M |
| 429 | NTRB | Nutriband Inc. | 42.18M | 0.58% | 3,040 | 2.04M |
| 430 | TVGN | Tevogen Bio Holdings Inc. | 41.88M | 1.32% | 2,624 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 41.33M | 1.16% | 14,661 | - |
| 432 | LITS | Lite Strategy, Inc. | 40.18M | 1.38% | 58,870 | - |
| 433 | QNTM | Quantum BioPharma Ltd. | 40.11M | -0.86% | 74,694 | - |
| 434 | MREO | Mereo BioPharma Group plc | 38.95M | 2.52% | 688,777 | 500.00K |
| 435 | INMB | INmune Bio Inc. | 38.28M | 2.13% | 89,274 | 50.00K |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 37.34M | 7.28% | 8,463 | - |
| 437 | DARE | Daré Bioscience, Inc. | 36.70M | 8.89% | 132,429 | 1.16M |
| 438 | RNXT | RenovoRx, Inc. | 36.52M | 0.57% | 49,923 | 1.49M |
| 439 | NNVC | NanoViricides, Inc. | 36.50M | 6.29% | 291,886 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 36.32M | 1.30% | 13,637 | 90.00K |
| 441 | LTRN | Lantern Pharma Inc. | 35.64M | 2.91% | 172,873 | - |
| 442 | GRCE | Grace Therapeutics, Inc. | 34.35M | 3.26% | 60,907 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 34.34M | 7.14% | 41,656 | 4.71M |
| 444 | VERU | Veru Inc. | 34.16M | 0.88% | 7,849 | 16.89M |
| 445 | NXTC | NextCure, Inc. | 34.10M | 3.52% | 6,673 | - |
| 446 | EVAX | Evaxion A/S | 32.96M | -0.70% | 8,522 | 7.53M |
| 447 | APLM | Apollomics, Inc. | 31.40M | 0.70% | 33 | 8.84M |
| 448 | BOLD | Boundless Bio, Inc. | 31.16M | -0.71% | 71,805 | - |
| 449 | SNTI | Senti Biosciences Holdings, Inc. | 29.09M | 6.09% | 81,614 | 38.00K |
| 450 | LSTA | Lisata Therapeutics, Inc. | 28.86M | 2.40% | 1,424 | 170.00K |
| 451 | IGC | IGC Pharma, Inc. | 28.78M | 3.30% | 80,954 | 1.11M |
| 452 | CRVO | CervoMed Inc. | 28.33M | 5.88% | 34,333 | 2.09M |
| 453 | BRNS | Barinthus Biotherapeutics plc | 27.77M | -0.53% | 1,263 | 14.97M |
| 454 | KYNB | Kyntra Bio, Inc. | 27.71M | 0.81% | 119 | 7.44M |
| 455 | PTN | Palatin Technologies, Inc. | 27.01M | 2.10% | 3,192 | 12.88M |
| 456 | DYAI | Dyadic International, Inc. | 26.95M | 2.60% | 1,906 | 3.81M |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 26.88M | -0.21% | 25,621 | - |
| 458 | SKYE | Skye Bioscience, Inc. | 26.83M | 5.31% | 46,553 | - |
| 459 | NEUP | Neuphoria Therapeutics Inc. | 26.31M | 2.31% | 23,689 | -13.27K |
| 460 | SER | Serina Therapeutics, Inc. | 26.15M | 9.01% | 57,379 | 130.00K |
| 461 | PLUR | Pluri Inc. | 25.98M | 2.58% | 4,029 | 1.08M |
| 462 | PLRZ | Polyrizon Ltd. | 25.70M | -1.79% | 18,539 | - |
| 463 | ABVC | ABVC BioPharma, Inc. | 25.70M | -5.45% | 18,501 | 797.92K |
| 464 | SNSE | Sensei Biotherapeutics, Inc. | 25.61M | 13.95% | 10,001 | - |
| 465 | TPST | Tempest Therapeutics, Inc. | 25.49M | -0.17% | 63,322 | - |
| 466 | BCTX | BriaCell Therapeutics Corp. | 25.44M | 4.27% | 101,971 | - |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 24.98M | 0.05% | 108,466 | 789.00K |
| 468 | OTLK | Outlook Therapeutics, Inc. | 24.97M | 4.51% | 912,027 | 333.14K |
| 469 | GRDX | GridAI Technologies Corp. | 24.18M | 1.30% | 8,104 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 23.93M | 4.47% | 28,236 | - |
| 471 | CELU | Celularity Inc. | 23.81M | 2.42% | 111,757 | 26.55M |
| 472 | MRKR | Marker Therapeutics, Inc. | 23.68M | 2.16% | 29,452 | 3.55M |
| 473 | TRAW | Traws Pharma, Inc. | 23.64M | -1.85% | 123,356 | 2.73M |
| 474 | ALLR | Allarity Therapeutics, Inc. | 23.35M | 1.34% | 72,557 | 345.00K |
| 475 | AEON | AEON Biopharma, Inc. | 22.73M | 1.06% | 3,755 | - |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.19M | -2.22% | 41,609 | 454.00K |
| 477 | LGVN | Longeveron Inc. | 20.50M | 3.97% | 242,338 | 1.22M |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 20.41M | -1.96% | 654,851 | 1.14M |
| 479 | CRIS | Curis, Inc. | 19.50M | 2.50% | 72,353 | 7.06M |
| 480 | XCUR | Exicure, Inc. | 18.80M | 2.08% | 10,415 | 500.00K |
| 481 | CLRB | Cellectar Biosciences, Inc. | 18.45M | 2.94% | 155,231 | - |
| 482 | LPCN | Lipocine Inc. | 18.16M | 2.85% | 14,381 | 2.00M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 18.10M | 3.32% | 156,732 | - |
| 484 | NCEL | NewcelX Ltd. | 17.81M | 4.03% | 2,228 | - |
| 485 | QNCX | Quince Therapeutics, Inc. | 17.44M | - | 547,881 | - |
| 486 | PASG | Passage Bio, Inc. | 16.78M | 2.95% | 6,542 | - |
| 487 | OSRH | OSR Holdings, Inc. | 16.64M | -1.51% | 354,183 | 2.63M |
| 488 | MTVA | MetaVia Inc. | 16.32M | 68.09% | 28,827,676 | - |
| 489 | HCWB | HCW Biologics Inc. | 16.03M | 124.53% | 101,681,579 | 6.59M |
| 490 | ICU | SeaStar Medical Holding Corporation | 15.79M | 1.54% | 25,318 | 1.44M |
| 491 | GNTA | Genenta Science S.p.A. | 15.57M | 5.91% | 30,143 | - |
| 492 | GDTC | CytoMed Therapeutics Limited | 15.50M | 8.26% | 14,596 | 669.28K |
| 493 | COCP | Cocrystal Pharma, Inc. | 15.44M | -2.61% | 29,909 | 225.00K |
| 494 | CVKD | Cadrenal Therapeutics, Inc. | 15.14M | -1.01% | 8,009 | - |
| 495 | INAB | IN8bio, Inc. | 15.07M | 5.52% | 18,985 | - |
| 496 | LEXX | Lexaria Bioscience Corp. | 14.87M | 3.93% | 30,265 | 368.00K |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 14.71M | -2.11% | 413,182 | 5.61M |
| 498 | HIND | Vyome Holdings, Inc. | 14.60M | 3.48% | 7,894 | 152.72K |
| 499 | GTBP | GT Biopharma, Inc. | 13.99M | 3.12% | 1,280,847 | - |
| 500 | ERNA | Ernexa Therapeutics Inc. | 13.59M | 1.75% | 42,683 | 1,000.00 |